Guggenheim Capital LLC Inari Medical, Inc. Transaction History

Guggenheim Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$54.2 - $71.67 $59,186 - $78,263	1,092 Added 11.02%	11,001 $719,000
Q2 2023 Aug 11, 2023	SELL	$56.23 - $71.17 $16,306 - $20,639	-290 Reduced 2.84%	9,909 $576,000
Q1 2023 May 10, 2023	SELL	$53.43 - $68.12 $63,902 - $81,471	-1,196 Reduced 10.5%	10,199 $629,000
Q4 2022 Feb 14, 2023	BUY	$61.23 - $83.62 $296,843 - $405,389	4,848 Added 74.05%	11,395 $724,000
Q3 2022 Nov 14, 2022	SELL	$65.58 - $84.69 $62,563 - $80,794	-954 Reduced 12.72%	6,547 $476,000
Q2 2022 Aug 15, 2022	BUY	$52.13 - $93.81 $391,027 - $703,668	7,501 New	7,501 $510,000

264

55.1M

137K

25.9K

Ticker NARI
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 53,389,700
Market Cap $2.52B
Description
Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of ...

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Guggenheim Capital LLC with notifications on news.